Ian A. Blair
A.N. Richards Professor of Pharmacology
Director, Center for Cancer Pharmacology, University of Pennsylvania School of Medicine
Investigator, Abramson Cancer Center, University of Pennsylvania School of Medicine
Member, Institute for Medicine and Engineering, University of Pennsylvania School of Medicine
Investigator, Genomics Institute, University of Pennsylvania School of Medicine
Scientific Director, Proteomics Core Laboratory, Genomics Institute and Abramson Cancer Center, University of Pennsylvania School of Medicine
Vice Chair, Department of Pharmacology, University of Pennsylvania School of Medicine
Scientific Director, Mass Spectrometry Facility, Department of Chemistry, University of Pennsylvania
Director, Program in Systems Biology, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine
Member, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine
Department: Pharmacology
Contact information
854 Biomedical Research Building II/III
University of Pennsylvania School of Medicine
Center for Cancer Pharmacology
421 Curie Boulevard
Philadelphia, PA 19104-6160
University of Pennsylvania School of Medicine
Center for Cancer Pharmacology
421 Curie Boulevard
Philadelphia, PA 19104-6160
Office: (215) 573-9880
Fax: (215) 573-9889
Fax: (215) 573-9889
Email:
ianblair@mail.med.upenn.edu
ianblair@mail.med.upenn.edu
Graduate Group Affiliations
Publications
Education:
Cambridge Grammar School for Boys, United Kingdom , 1960.
Prince of Wales School, Nairobi, Kenya, 1963.
B.Sc. ((Special) Chemistry, ARCS)
Imperial College of Science and Technology, University of London, United Kingdom, 1968.
Ph.D.
Imperial College of Science and Technology, University of London, United Kingdom, 1971.
MRSC (Organic Chemistry)
Adelaide University, Australia, 1972.
ARACI
Australian National University, 1977.
Cambridge Grammar School for Boys, United Kingdom , 1960.
Prince of Wales School, Nairobi, Kenya, 1963.
B.Sc. ((Special) Chemistry, ARCS)
Imperial College of Science and Technology, University of London, United Kingdom, 1968.
Ph.D.
Imperial College of Science and Technology, University of London, United Kingdom, 1971.
MRSC (Organic Chemistry)
Adelaide University, Australia, 1972.
ARACI
Australian National University, 1977.
Links
Search PubMed for articles
Center for Cancer Pharmacology, Blair Lab webpage. Department of Pharmacology, Faculty Webpage
Permanent linkSearch PubMed for articles
Center for Cancer Pharmacology, Blair Lab webpage. Department of Pharmacology, Faculty Webpage
Description of Research Expertise
Oxidative stress, carcinogenesis, cardiovascular disease, and neurodegenerative diseaseOxidative stress results in damage to lipids through the formation of lipid hydroperoxides. Our laboratory is involved in determining the factors that control lipid hydroperoxide-mediated damage to DNA, and proteins. We are also characterizing the lesions in these macromolecules using novel mass spectrometry methodology, determining how the lesions affect proliferation and apoptosis using model in vitro systems, and assessing how such processes can be prevented using novel pharmacological agents. We also have a program in biomarker discovery and analysis, which is focused on metabolomic and proteomic biomarkers of smoking, pancreatic cancer, breast cancer, and neurodegenerative diseases. This involves the use of quantitative stable isotope dilution liquid chromatography-mass spectrometry methodology. We recently implement the use of stable isotope dilution by essential nutrients in cell culture (SILEC) as a method for analyzing important Krebs cycle coenzyme A-thioesters. This has made it possible to examine the effects of chemicals and disease on mitochondrial dysfunction.
Description of Itmat Expertise
Dr. Blair is interested in oxidative stress in cancer, cardiovascular disease, and neurodegenerative disease including the investigation of the role of endogenous DNA- and glutathione-adducts as biomarkers of cancer and cardiovascular disease in vitro, in animal models and humans. He is also developing metabolomic biomarkers of neurodegenerative diseases in humans and in animal models.Selected Publications
DeNicola Gina M, Karreth Florian A, Humpton Timothy J, Gopinathan Aarthi, Wei Cong, Frese Kristopher, Mangal Dipti, Yu Kenneth H, Yeo Charles J, Calhoun Eric S, Scrimieri Francesca, Winter Jordan M, Hruban Ralph H, Iacobuzio-Donahue Christine, Kern Scott E, Blair Ian A, Tuveson David A: Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475(7354): 106-9, Jul 2011.Jin Yi, Mesaros A Clementina, Blair Ian A, Penning Trevor M: Stereospecific reduction of 5β-reduced steroids by human ketosteroid reductases of the AKR (aldo-keto reductase) superfamily: role of AKR1C1-AKR1C4 in the metabolism of testosterone and progesterone via the 5β-reductase pathway. The Biochemical journal 437(1): 53-61, Jul 2011.
Zhang Li, Jin Yi, Chen Mo, Huang Meng, Harvey Ronald G, Blair Ian A, Penning Trevor M: Detoxication of Structurally Diverse Polycyclic Aromatic Hydrocarbon (PAH) o-Quinones by Human Recombinant Catechol-O-methyltransferase (COMT) via O-Methylation of PAH Catechols. The Journal of biological chemistry 286(29): 25644-54, Jul 2011.
Wehr Angela Y, Furth Emma E, Sangar Vineet, Blair Ian A, Yu Kenneth H: Analysis of the human pancreatic stellate cell secreted proteome. Pancreas 40(4): 557-66, May 2011.
Mitra Ranjana, Lee Jinseon, Jo Jisuk, Milani Monica, McClintick Jeanette N, Edenberg Howard J, Kesler Kenneth A, Rieger Karen M, Badve Sunil, Cummings Oscar W, Mohiuddin Ahmed, Thomas Dafydd G, Luo Xianghua, Juliar Beth E, Li Lang, Mesaros Clementina, Blair Ian A, Srirangam Anjaiah, Kratzke Robert A, McDonald Clement J, Kim Jhingook, Potter David A: Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model. Clinical cancer research : an official journal of the American Association for Cancer Research 17(9): 2934-46, May 2011.
Mitra Ranjana, Guo Zhijun, Milani Monica, Mesaros Clementina, Rodriguez Mariangellys, Nguyen Julia, Luo Xianghua, Clarke Duncan, Lamba Jatinder, Schuetz Erin, Donner David B, Puli Narender, Falck John R, Capdevila Jorge, Gupta Kalpna, Blair Ian A, Potter David A: CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET). The Journal of biological chemistry 286(20): 17543-59, May 2011.
Rangiah Kannan, Shah Sumit J, Vachani Anil, Ciccimaro Eugene, Blair Ian A: Liquid chromatography/mass spectrometry of pre-ionized Girard P derivatives for quantifying estrone and its metabolites in serum from postmenopausal women. Rapid communications in mass spectrometry : RCM 25(9): 1297-307, May 2011.
Rangiah Kannan, Hwang Wei-Ting, Mesaros Clementina, Vachani Anil, Blair Ian A: Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS. Bioanalysis 3(7): 745-61, Apr 2011.
Basu Sankha S, Mesaros Clementina, Gelhaus Stacy L, Blair Ian A: Stable isotope labeling by essential nutrients in cell culture for preparation of labeled coenzyme A and its thioesters. Analytical chemistry 83(4): 1363-9, Feb 2011.
Johnson Thomas V, Gupta Preeya K, Vudathala Daljit K, Blair Ian A, Tanna Angelo P: Thermal stability of bimatoprost, latanoprost, and travoprost under simulated daily use. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 27(1): 51-9, Feb 2011.

